Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180346 | SCV000232759 | benign | not specified | 2015-02-24 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004707847 | SCV005246071 | benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000001189 | SCV000021339 | risk factor | Inflammatory bowel disease 10, susceptibility to | 2014-02-27 | no assertion criteria provided | literature only | |
Prevention |
RCV003982820 | SCV004796357 | benign | ATG16L1-related disorder | 2019-10-17 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |